[Control of myocardial metabolism by verapamil. Sites of action and therapeutic effects].
D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology* / Q000627:therapeutic use; D002118:Calcium / Q000037:antagonists & inhibitors; D002463:Cell Membrane Permeability; D006168:Guinea Pigs; D006321:Heart / Q000187:drug effects*; D006329:Heart Conduction System; D006801:Humans; D000860:Hypoxia / Q000188:drug therapy; D007474:Ion Exchange; D009206:Myocardium / Q000378:metabolism* / Q000473:pathology; D009336:Necrosis; D009570:Nitriles / Q000494:pharmacology* / Q000627:therapeutic use; D010101:Oxygen Consumption; D014665:Vasodilator Agents / Q000494:pharmacology* / Q000627:therapeutic use; D014700:Verapamil / Q000494:pharmacology / Q000627:therapeutic use
D000889:Anti-Arrhythmia Agents; D009570:Nitriles; D014665:Vasodilator Agents; D014700:Verapamil; D002118:Calcium
Die Zügelung des Myocardstoffwechsels durch Verapamil. Angriffspunkte und Anwendungsmöglighkeiten.